Top Markets
#1 Black Phoenix Black Phoenix +335.94%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +66.31%
#4 Gold Park Gold Park +58.04%
#5 Acurast Acurast +39.65%
#6 OpenEden OpenEden +34.31%
#7 BasedHype BasedHype +27.14%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +21.88%
#9 Cryptopia Cryptopia +21.54%
#10 Avantis Avantis +18.65%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Asarina Pharma AB (publ) Asarina Pharma AB (publ)

Asarina Pharma AB (publ)

ASAP
Rank in Stocks #40859
Asarina Pharma AB (publ) is a biotech enterprise, specializing in the research... Asarina Pharma AB (publ) is a biotech enterprise, specializing in the research and development of pharmaceutical products. Their key therapeutic agent, Sepranolone, is developed to address menstrual migraine and Tourette syndrome. Founded in 2005, this Solna, Sweden-based company was previously known as Umecrine Mood AB before officially changing its name to Asarina Pharma AB (publ) in 2016.
Share Price
$0.00312742
Last synced: 2024-10-01
Market Cap
$70.81K
Change (1 day)
-21.83%
Change (1 year)
0.00%
Country
SE
Trade Asarina Pharma AB (publ) (ASAP)

Category

Healthcare
Revenue for Asarina Pharma AB (publ) (ASAP)
Revenue in Dec 2023 TTM: 0.00
According to Asarina Pharma AB (publ) latest financial reports the company's current revenue (TTM) is 0.00. In 2022 the company made a revenue of 0.00 equal to the revenue in the year 2021 that was 0.00. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Asarina Pharma AB (publ) from 2017 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) 0.00 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE